PT Bank Mandiri (Persero) Tbk. (BMRI) Stock: Financial Analysis, Business Strength and the Indonesian Investor Perspective
Published: June 1, 2026
Last Updated: June1, 2026
Financial data and analysis reviewed as of June 1, 2026.
 |
| PT Bank Mandiri (Persero) Tbk. (BMRI) |
Worldreview1989 -BMRI offers investors exposure to one of Indonesia’s largest banking franchises, with strong loan growth, a large low-cost deposit base and improving asset quality. The key question for investors is not simply whether Bank Mandiri is growing, but whether that growth can continue without putting pressure on margins, credit quality and returns on equity.
Reader perspective: This analysis is written for readers in Indonesia who follow BMRI as an IDX-listed banking stock. It focuses on the factors that local investors commonly need to examine: credit growth, deposits, NPL, profitability, capital, interest rates, valuation and dividend potential.
BMRI at a Glance
PT Bank Mandiri (Persero) Tbk. is one of Indonesia's major state-owned banks and is listed on the Indonesia Stock Exchange under the ticker BMRI.
According to Bank Mandiri's investor-relations data, as of June 2026, the bank reported:
| Indicator | June 2026 |
|---|---|
| Total Assets | Rp2,528 trillion |
| Total Loans | Rp1,677 trillion |
| NPL | 1.01% |
| Third-Party Funds | Rp1,763 trillion |
| CASA Ratio | 69.2% |
| Bank-only LDR | 92.3% |
| Net Profit | Rp30.4 trillion |
| ROE | 20.9% |
| CAR | 17.9% |
These figures demonstrate the scale of BMRI's balance sheet and, particularly, the importance of its low-cost CASA funding base. (Bank Mandiri)
Check : Indonesia Stock Exchange Listed Companies Directory
What Is Happening With BMRI's Business?
One of the most important developments in 2026 has been the acceleration of lending.
Bank Mandiri reported bank-only loans of Rp1,592 trillion as of June 2026, representing 19.9% year-on-year growth. This was substantially above the 12.7% industry credit growth reported by Bank Indonesia for the same period. (Bank Mandiri)
At the same time, bank-only third-party funds reached approximately Rp1,710 trillion, up 17.1% YoY.
This is important because a bank cannot sustainably expand lending simply by increasing its loan book. It needs a corresponding funding base.
BMRI's funding structure is particularly important
The CASA ratio was 69.2% at June 2026 according to Bank Mandiri's investor-relations data. (Bank Mandiri)
CASA — current accounts and savings accounts — is strategically important because these deposits generally provide cheaper funding than time deposits.
For investors, the analytical question is therefore:
Can BMRI maintain strong loan growth while preserving its low-cost funding advantage?
If the answer remains yes, BMRI can potentially support attractive profitability even when interest-rate conditions become more competitive.
BMRI Profitability Analysis
Bank Mandiri reported Rp30.4 trillion of net profit through June 2026, while its reported ROE was 20.9%. (Bank Mandiri)
ROE is one of the most useful metrics for analyzing a bank because it measures how effectively shareholders' capital is being converted into earnings.
A simplified interpretation is:
ROE = Net Income ÷ Average Equity
An ROE above 20% indicates that the bank is generating substantial earnings relative to its equity base.
However, investors should avoid looking at ROE in isolation.
A high ROE can sometimes result from high leverage or aggressive risk-taking. In BMRI's case, the more interesting combination is:
strong loan growth,
high CASA funding,
controlled NPL,
substantial capital,
and ROE above 20%.
That combination provides more information about the underlying banking franchise than ROE alone.
Credit Quality: An Important BMRI Strength
 |
| PT Bank Mandiri (Persero) Tbk. (BMRI) |
Rapid loan growth naturally creates concerns about future credit losses.
Bank Mandiri reported a bank-only gross NPL of 0.98% as of June 2026, improving by 10 basis points year-on-year. Its cost of credit was 0.52%, while NPL coverage stood at 242%. (Bank Mandiri)
This combination is worth watching.
The bank is expanding credit quickly, but reported problem loans have remained relatively contained.
Why NPL coverage matters
Suppose a bank has:
Rp100 billion of NPL
Rp242 billion of provisions
The NPL coverage ratio would be approximately:
Rp242 billion ÷ Rp100 billion = 242%
This does not eliminate credit risk, but it provides a significant accounting buffer against potential deterioration.
For BMRI investors, therefore, the future direction of NPL and cost of credit may be more important than simply looking at current loan growth.
BMRI Versus the Indonesian Banking Environment
The broader banking industry provides useful context.
According to OJK, Indonesian banking credit grew 13.58% YoY in July 2026, reaching approximately Rp9,135 trillion. Credit growth was particularly strong in investment loans, which grew 25.13% YoY. (OJK)
At the industry level:
| Banking Indicator | July 2026 |
|---|---|
| Credit growth | 13.58% YoY |
| Deposit growth | 11.21% YoY |
| Gross NPL | 2.10% |
| Net NPL | 0.81% |
| ROA | 2.45% |
| CAR | 23.84% |
(OJK)
BMRI's bank-only loan growth of 19.9% in June was therefore materially above the broader industry's growth rate. (Bank Mandiri)
This creates an interesting analytical situation:
BMRI is growing faster than the banking system, but investors need to monitor whether that growth differential remains profitable and sustainable.
Interest Rates Matter for BMRI
Bank Indonesia kept the BI-Rate at 5.75% on September 23, 2026. BI also reported that Indonesian banking credit grew 13.65% YoY in August 2026. (Badan Pusat Statistik)
For a bank such as BMRI, interest rates affect several variables simultaneously:
Loan pricing
Deposit costs
Net interest margin
Credit demand
Bond portfolio valuation
Borrower repayment capacity
A lower interest-rate environment can stimulate credit demand, but it can also create competition among banks for quality borrowers.
Therefore, investors should not automatically assume that falling rates are always positive for BMRI.
The more useful question is:
How much of the benefit from lower funding costs can BMRI retain after competition affects loan pricing?
Digital Banking Is Becoming a Competitive Moat
Bank Mandiri's digital ecosystem is another important part of its business model.
The bank reported that Kopra by Mandiri had approximately 354,000 registered users by June 2026, up 26.8% YoY, with around 84% of users being MSMEs. (Bank Mandiri)
This matters beyond the technology itself.
A successful digital platform can increase:
transaction frequency,
customer retention,
fee income,
deposit relationships,
cross-selling,
and operating efficiency.
The unique analytical point is that Kopra should not be viewed only as a digital-banking product.
It can also function as an ecosystem tool that helps BMRI connect corporate customers, SMEs, payments and financing.
That potentially makes the deposit relationship more valuable over time.
BMRI Dividend Perspective
 |
| PT Bank Mandiri (Persero) Tbk. (BMRI) |
For income-oriented investors, BMRI's dividend policy is an important part of the investment case.
But dividend analysis should be performed together with:
annual net profit,
payout ratio,
capital adequacy,
loan growth,
retained earnings,
and government/shareholder decisions.
A bank experiencing rapid loan growth may retain more earnings to support balance-sheet expansion.
Therefore, a high dividend today does not automatically mean the highest long-term shareholder return.
Investors should examine total shareholder return, consisting of:
Share-price appreciation + dividends
rather than looking only at dividend yield.
BMRI Valuation: What Investors Should Calculate
For banks, conventional industrial-company metrics such as EV/EBITDA are generally less useful.
BMRI investors should focus on:
1. Price-to-Book Value — PBV
PBV = Market Capitalization ÷ Book Value
PBV is especially relevant for banks because equity capital is an important component of their operating model.
A bank capable of producing consistently high ROE can potentially justify trading at a premium to book value.
2. Price-to-Earnings — PER
PER = Share Price ÷ EPS
PER provides a simple way to compare BMRI with other listed banks.
3. ROE
ROE helps determine whether a premium PBV is supported by the bank's profitability.
4. Dividend Yield
Dividend Yield = Annual Dividend ÷ Share Price
This is useful for income-focused investors.
A Better Way to Analyze BMRI Valuation
One useful framework is to compare:
PBV ↔ ROE ↔ Cost of Equity
For example, if a bank consistently produces strong ROE while maintaining acceptable asset quality and capital adequacy, investors may be willing to pay more than book value.
Conversely, if ROE declines because:
net interest margins contract,
credit costs increase,
loan growth slows,
or operating expenses rise,
then the valuation premium can become harder to justify.
This is more informative than simply saying that BMRI has a "cheap" or "expensive" stock price.
2026 BMRI Investor Dashboard
For local Indonesian readers, I would monitor these indicators every quarter:
| Metric | Why It Matters |
|---|---|
| Loan growth | Measures business expansion |
| CASA ratio | Measures funding quality |
| NIM | Measures lending profitability |
| NPL | Measures credit quality |
| Cost of credit | Measures credit-loss pressure |
| NPL coverage | Measures provision buffer |
| ROE | Measures shareholder profitability |
| CAR | Measures capital strength |
| LDR | Measures funding/intermediation balance |
| Fee income | Measures non-interest revenue |
| Operating expense | Measures efficiency |
| Dividend payout | Measures cash return to shareholders |
The most important combination is not necessarily the highest loan growth.
A stronger signal would be:
Loan growth + stable CASA + controlled NPL + manageable cost of credit + high ROE.
That combination indicates growth that is being converted into shareholder returns without an obvious deterioration in risk metrics.
Key Risks for BMRI Investors
Despite its scale, BMRI is not risk-free.
1. Credit-cycle risk
Fast credit growth can eventually lead to higher NPLs if economic conditions deteriorate.
2. Net interest margin pressure
Competition for deposits and borrowers can reduce margins.
3. Interest-rate risk
Changes in monetary policy can influence funding costs, loan demand and investment portfolios.
4. Economic concentration
As one of Indonesia's largest banks, BMRI has significant exposure to the domestic economy.
5. Government-related exposure
As a state-owned bank, BMRI participates in various government-related programs and economic initiatives. This can create business opportunities but also means investors should examine the commercial economics and risk characteristics of individual programs.
6. Valuation risk
A financially strong company can still produce disappointing investment returns if purchased at an excessive valuation.
This is one of the most important distinctions for stock investors:
Good company ≠ automatically good entry price.
BMRI vs. the Indonesian Banking Cycle
The current macro picture provides both opportunities and questions.
Bank Indonesia reported that August 2026 credit growth reached 13.65% YoY, while DPK grew 10.94% YoY. BI continues to use macroprudential incentives to encourage banking intermediation. (Badan Pusat Statistik)
OJK also reported that banking-sector CAR remained high at 23.84% in July 2026, while gross NPL was 2.10%. (OJK)
This suggests that the broader Indonesian banking system entered the second half of 2026 with substantial capital buffers.
For BMRI, the opportunity is to convert this supportive banking environment into sustainable earnings growth.
The risk is that aggressive competition could eventually reduce the profitability of incremental lending.
What Makes BMRI Interesting to Local Readers?
From the perspective of Indonesian investors, BMRI is more than simply a bank stock.
It provides exposure to several parts of the domestic economy:
corporate lending,
infrastructure,
government-related economic activity,
consumer banking,
MSMEs,
digital payments,
trade finance,
cash management,
and investment banking.
Its enormous customer and transaction ecosystem can potentially create cross-selling opportunities that smaller banks cannot replicate as easily.
The key analytical question is therefore not:
"Is Bank Mandiri a large bank?"
That is already clear.
The more useful question is:
"Can Bank Mandiri continue converting its scale into superior returns without materially increasing credit and funding risks?"
The 2026 data provide several metrics to monitor: loan growth, CASA, NPL, cost of credit, ROE and capital adequacy. (Bank Mandiri)
Conclusion
PT Bank Mandiri (Persero) Tbk. (BMRI) represents a major Indonesian banking franchise with strong balance-sheet scale, rapid 2026 loan growth, a high CASA ratio, controlled credit quality and strong profitability.
As of June 2026, Bank Mandiri reported Rp30.4 trillion in net profit, 20.9% ROE, 69.2% CASA and 17.9% CAR on its investor-relations snapshot, while bank-only loans grew 19.9% YoY. (Bank Mandiri)
For investors, however, the next stage of analysis should focus on valuation rather than business quality alone.
A useful BMRI investment framework is:
Earnings growth → ROE → asset quality → funding cost → capital → valuation → dividend.
Investors should compare BMRI's current share price, PBV, PER, dividend yield and expected earnings against other Indonesian banks and against their own required return before making an investment decision.
Data note: Financial figures above are based primarily on Bank Mandiri's June 2026 investor-relations disclosures and Bank Mandiri's July 2026 release, while industry figures use OJK and Bank Indonesia publications available through September 2026. (Bank Mandiri)
Primary Sources & References
Bank Mandiri Investor Relations — corporate snapshot, financial information and investor materials. (Bank Mandiri)
Bank Mandiri Quarterly Financials — quarterly financial statements and 2026 reporting. (Bank Mandiri)
Bank Indonesia — monetary policy and Indonesian banking-system data. (Badan Pusat Statistik)
OJK — banking-sector credit, NPL, ROA, CAR and liquidity statistics. (OJK)
About the Author
David Mulyana is the founder and editor of WorldReview1989, an independent publication dedicated to finance, investing, insurance, business, technology, and digital marketing.
He researches and writes in-depth articles that help readers understand complex financial topics through clear explanations, practical insights, and data-driven analysis. His editorial focus includes stock market investing, cryptocurrencies, banking, personal finance, business insurance, real estate, startup strategies, and emerging technology trends.
Every article published on WorldReview1989 is created with a commitment to accuracy, transparency, and reader value. Content is reviewed regularly to reflect the latest market developments, industry updates, and publicly available information from trusted sources.
Editorial Principles
- Accuracy before speed
- Independent and unbiased analysis
- Clear, easy-to-understand explanations
- Information supported by reputable public sources
- Regular updates to maintain content relevance
Areas of Expertise
- Alternative Assets
- Business & Startups
- Franchise
- Insurance
- Property and Real Estate
- Stocks
About WorldReview1989
WorldReview1989 provides educational content for readers seeking reliable information about finance, investment opportunities, insurance, business strategies, and technology. The website aims to simplify complex financial concepts and empower readers to make informed decisions.
Disclaimer: The information published on WorldReview1989 is for educational and informational purposes only. It should not be considered financial, legal, tax, or investment advice. Readers should consult qualified professionals before making financial decisions.
David Mulyana writes about stocks, financial markets, investment strategies, insurance and emerging-market opportunities, with a focus on helping readers understand financial data and investment risks.